Submitted:
08 December 2023
Posted:
08 December 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Subjects
2.2. Epidemiologic conditions and questionnaire on complaints
2.3. Standard neurological examination
2.4. Quantitative sensory measurements
2.4.1. Minimal tactile sense by Semmes-Weinstein monofilaments
2.4.2. Vibration sense
2.4.3. Position sense
2.4.4. Two-point discrimination sense
2.5. Neurophysiologic, neuroradiological, and other laboratory tests
2.6. Statistical methods
2.6.1. Questionnaire and neurological examination
2.6.2. Percentage of touch and pain disturbance
2.6.3. Relationship between complaints and sensory disturbance level
2.6.4. Relationship between touch disturbance category (V-I) and results of quantitative sensory measurements, perimeter, and audiometry
2.6.5. Relationship minimal tactile sense and two-point discrimination
2.6.6. Relationship between quantitative sensory measurements and results of evoked electromyography
3. Results
3.1. Backgrounds of subjects
3.2. Complaints and neurological examination
3.3. Comparison of touch and pain disturbance
3.4. Relationship between complaints and sensory disturbance level (Level 4-0)
3.5. Relationship between touch disturbance categories (V-I) and quantitative sensory measurements, perimeter, and audiometry
3.6. Relationship between minimal tactile sense and two-point discrimination sense
3.7. Relationship between quantitative sensory measurements and results of evoked electromyography
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Edwards, G. Two cases of poisoning by mercuric methide. Saint Bartholomew’s Hosp Rep. 1865, 1, 141–150. [Google Scholar]
- Hunter, D.; Bomford, R.R.; RUssell, D.S. Poisoning by methyl mercury compounds. quarterly Journal of Medicine. 1940, 9, 193–213. [Google Scholar]
- Harada, M. Minamata disease: methylmercury poisoning in Japan caused by environmental pollution. Crit Rev Toxicol. 1995, 25, 1–24. [Google Scholar] [CrossRef]
- Bakir, F.; Rustam, H.; Tikriti, S.; Al-Damluji, S.F.; Shihristani, H. Clinical and epidemiological aspects of methylmercury poisoning. Postgrad Med J. 1980, 56, 1–10. [Google Scholar] [CrossRef]
- Kjellstrom, T.; Kennedy, P.; Wallis, S.; Stewart, A.; Freiberg, L.; Lind, B.; al., e. Physical and Mental Development of Children with Prenatal Exposure to Mercury from Fish. Stage II. Interviews and Psychological Tests at Age 6. Report 3642.; Swedish Environmental Protection Board; Solna, Sweden, 1989.
- Grandjean, P.; Weihe, P.; White, R.F.; Debes, F.; Araki, S.; Yokoyama, K.; Murata, K.; Sorensen, N.; Dahl, R.; Jorgensen, P.J. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol Teratol. 1997, 19, 417–428. [Google Scholar] [CrossRef]
- Karagas, M.R.; Choi, A.L.; Oken, E.; Horvat, M.; Schoeny, R.; Kamai, E.; Cowell, W.; Grandjean, P.; Korrick, S. Evidence on the human health effects of low-level methylmercury exposure. Environ Health Perspect. 2012, 120, 799–806. [Google Scholar] [CrossRef]
- Kurland, L.T.; Faro, S.N.; Siedler, H. Minamata disease. The outbreak of a neurologic disorder in Minamata, Japan, and its relationship to the ingestion of seafood contaminated by mercuric compounds. World Neurol. 1960, 1, 370–395. [Google Scholar] [PubMed]
- Tsubaki, T. Tracking Minamata Disease in Niigata (in Japanese). Kagaku. 1972, 42, 526–531. [Google Scholar]
- Tsubaki, T. Recent Problems Regarding the Diagnosis of Minamata Disease (in Japanese). Shinkei Kenkyu No Shimpo. 1974, 18, 882–889. [Google Scholar]
- Ekino, S.; Ninomiya, T.; Imamura, K.; Susa, M. Methylmercury causes diffuse damage to the somatosensory cortex: how to diagnose Minamata disease (in Japanese). Seishin Shinkeigaku Zasshi. 2007, 109, 420–437. [Google Scholar] [PubMed]
- Ninomiya, T.; Imamura, K.; Kuwahata, M.; Kindaichi, M.; Susa, M.; Ekino, S. Reappraisal of somatosensory disorders in methylmercury poisoning. Neurotoxicol Teratol. 2005, 27, 643–653. [Google Scholar] [CrossRef] [PubMed]
- Takaoka, S.; Kawakami, Y.; Fujino, T.; Oh-ishi, F.; Motokura, F.; Kumagai, Y.; Miyaoka, T. Somatosensory disturbance by methylmercury exposure. Environ Res. 2008, 107, 6–19. [Google Scholar] [CrossRef] [PubMed]
- Uchino, M.; Araki, S. Clinical features of chronic Minamata disease (organic mercury poisoning). Analysis of the neurological findings in the most recent 100 cases (in Japanese). Rinsho Shinkeigaku. 1984, 24, 235–239. [Google Scholar] [PubMed]
- Katsuki, S.; Tokuomi, H.; Okajima, T.; Kanai, J.; Tsunoda, M.; Ishizaka, K.; Hidaka, T.; Akashi, A.; Iemura, T.; Shimada, T.; Kawamur, a.S.; Miyawaki, Y.; Ichiyasu, Y.; Matsuzaki, T.; Honjo, S.; Moriyama, E.; Misumi, H.; Tsuchimochi, T.; Hiraoka, T. Central nervous disease of unknown origin occurred in Minamata district - especially on clinical observations (in Japanese). Kumamoto Medical Journal. 1957, 31, 23–36. [Google Scholar]
- Le Quesne, P.M.; Damluji, S.F.; Rustam, H. Electrophysiological studies of peripheral nerves in patients with organic mercury poisoning. J Neurol Neurosurg Psychiatry. 1974, 37, 333–339. [Google Scholar] [CrossRef] [PubMed]
- Snyder, R.D.; Seelinger, D.F. Methylmercury poisoning, Clinical follow-up and sensory nerve conduction studies. J Neurol Neurosurg Psychiatry. 1976, 39, 701–704. [Google Scholar] [CrossRef]
- Oliveira, R.A.A.; Pinto, B.D.; Reboucas, B.H.; Ciampi de Andrade, D.; Vasconcellos, A.C.S.; Basta, P.C. Neurological Impacts of Chronic Methylmercury Exposure in Munduruku Indigenous Adults: Somatosensory, Motor, and Cognitive Abnormalities. Int J Environ Res Public Health. 2021, 18. [Google Scholar] [CrossRef]
- Khoury, E.D.; Souza Gda, S.; da Costa, C.A.; de Araujo, A.A.; de Oliveira, C.S.; Silveira, L.C.; Pinheiro Mda, C. Somatosensory Psychophysical Losses in Inhabitants of Riverside Communities of the Tapajos River Basin, Amazon, Brazil: Exposure to Methylmercury Is Possibly Involved. PLoS One. 2015, 10, e0144625. [Google Scholar] [CrossRef]
- Nierenberg, D.W.; Nordgren, R.E.; Chang, M.B.; Siegler, R.W.; Blayney, M.B.; Hochberg, F.; Toribara, T.Y.; Cernichiari, E.; Clarkson, T. Delayed cerebellar disease and death after accidental exposure to dimethylmercury. N Engl J Med. 1998, 338, 1672–1676. [Google Scholar] [CrossRef]
- Kandel, E.R. Nerve Cell and Behavior. In Principles of Neural Science, 4 ed.; kandel, E.R., Schwartz, J.H., Jessell, T.M., Eds.; McGraw-Hill Companies: New York, 2000; p. 34. [Google Scholar]
- Miura, K.; Suzuki, K.; Imura, N. Effects of methylmercury on mitotic mouse glioma cells. Environ Res. 1978, 17, 453–471. [Google Scholar] [CrossRef]
- Imura, N.; Miura, K.; Inokawa, M.; Nakada, S. Mechanism of methylmercury cytotoxicity: by biochemical and morphological experiments using cultured cells. Toxicology. 1980, 17, 241–254. [Google Scholar] [CrossRef] [PubMed]
- Ben-Ze'ev, A.; Farmer, S.R.; Penman, S. Mechanisms of regulating tubulin synthesis in cultured mammalian cells. Cell. 1979, 17, 319–325. [Google Scholar] [CrossRef]
- Sager, P.R.; Doherty, R.A.; Olmsted, J.B. Interaction of methylmercury with microtubules in cultured cells and in vitro. Exp Cell Res. 1983, 146, 127–137. [Google Scholar] [CrossRef] [PubMed]
- Kawamori, Y.; Tokuomi, H.; Okajima, T.; Kanai, J.; Tsunoda, M.; Ishizaka, K.; Murohara, I.; Akatsuka, A.; Iemura, T.; Yonemitsu, K.; Kawamur, a.S.; Miyawaki, Y.; Kashiwada, T.; Nagaki, J.; Shimada, T.; Maeyama, N.; Ichiyasu, Y.; Matsuzaki, T.; Honjo, S.; Misumi, H.; Moriyama, E.; Tsuchimochi, T.; Hiraoka, T.; Maeda, T. Central nervous disease of unknown origin occurred in Minamata district - follow-up report (in Japanese). Kumamoto Medical Journal. 1957, 31, 251–261. [Google Scholar]
- Tatetsu, S.; Murayama, E.; Harada, M.; Miyakawa, T. Sequelae of acquired Minamata disease. Symptoms and changes 4 1/2 - 7 1/2 years from onset (in Japanese). Shinkei Kenkyu No Shimpo. 1969, 13, 76–83. [Google Scholar] [PubMed]
- Weiss, B.; Clarkson, T.W.; Simon, W. Silent latency periods in methylmercury poisoning and in neurodegenerative disease. Environ Health Perspect. 2002, 110 Suppl 5, 851–854. [Google Scholar] [CrossRef]
- Takaoka, S.; Fujino, T.; Kawakami, Y.; Shigeoka, S.I.; Yorifuji, T. Survey of the Extent of the Persisting Effects of Methylmercury Pollution on the Inhabitants around the Shiranui Sea, Japan. Toxics. 2018, 6. [Google Scholar] [CrossRef]
- Shirakawa, K. Delayed Onset Minamata disease (in Japanese). In Minamata Disease -20 Years of Research and Current Challenges-; Arima, S., Ed.; Seirin-sha: Tokyo, 1979; pp. 331–344. [Google Scholar]
- Louis, E.D. Merritt’s Neurology (14th Edition); Lippincott Williams & Wilkins; Philadelphia, 2021.
- Axelrod, F.B.; Gold-von Simson, G. Hereditary sensory and autonomic neuropathies: types II, III, and IV. Orphanet J Rare Dis. 2007, 2, 39. [Google Scholar] [CrossRef]
- Sterman, A.B.; Schaumburg, H.H.; Asbury, A.K. The acute sensory neuronopathy syndrome: a distinct clinical entity. Ann Neurol. 1980, 7, 354–358. [Google Scholar] [CrossRef]
- Bakir, F.; Damluji, S.F.; Amin-Zaki, L.; Murtadha, M.; Khalidi, A.; al-Rawi, N.Y.; Tikriti, S.; Dahahir, H.I.; Clarkson, T.W.; Smith, J.C.; Doherty, R.A. Methylmercury poisoning in Iraq. Science. 1973, 181, 230–241. [Google Scholar] [CrossRef]
- Living Hygiene Division, M.o.H.a.W., Niigata Prefecture Niigata Mercury Poisoning Incident Special Study Report (Ministry of Health and Welfare, Research Division), 1967.
- Cinca, I.; Dumitrescu, I.; Onaca, P.; Serbanescu, A.; Nestorescu, B. Accidental ethyl mercury poisoning with nervous system, skeletal muscle, and myocardium injury. J Neurol Neurosurg Psychiatry. 1980, 43, 143–149. [Google Scholar] [CrossRef]
- Nagaki, J.; Ohnishi, A.; Kuroiwa, Y. Electrophysiologic and histopathologic studies on sural nerves from Minamata disease patients of delayed onset showing distal sensory impairments (in Japanese). Rinsho Shinkeigaku. 1985, 25, 88–94. [Google Scholar] [PubMed]
- Hunter, D.; Russell, D.S. Focal cerebral and cerebellar atrophy in a human subject due to organic mercury compounds. J Neurol Neurosurg Psychiatry. 1954, 17, 235–241. [Google Scholar] [CrossRef]
- Takeuchi, T.; Kambara, T.; Morikawa, N.; Matsumoto, H.; Shiraishi, Y.; Ito, H. Pathologic observations of the Minamata disease. Acta Pathol Jpn. 1959, 9 (Suppl), 769–783. [Google Scholar] [CrossRef] [PubMed]
- Eto, K.; Okajima, T. Clinico-pathological Study on the Autopsy Cases Showing Glove-and-stocking Type Sensory Disturbance in Relation to Minamata Disease (in Japanese). Kumamoto Medical Journal. 1994, 68, 59–71. [Google Scholar]
- Dyck, P.T. Pathology of the peripheral nervous system. In Peripheral Neuropathy, third edition ed.; Dyck, P.T., Thomas, P.K., Eds.; W.B. Saunders Company: Philadelphia, 1993; p. 533. [Google Scholar]
- Eto, K.; Tokunaga, H.; Nagashima, K.; Takeuchi, T. An autopsy case of minamata disease (methylmercury poisoning)--pathological viewpoints of peripheral nerves. Toxicol Pathol. 2002, 30, 714–722. [Google Scholar] [CrossRef] [PubMed]
- Eto, K. Two autopsy cases of clinical Minamata disease without pathological findings of organic mercury toxicosis (in Japanese). Neuropathology. 1988, 8, 289–300. [Google Scholar]
- Ikuta, F. LETTERS The reality underlying the diagnosis, recognition and sentencing of Minamata disease symptoms: from the number of nerve cell dropouts (in Japanese). BRAIN and NERVE. 2018, 70, 938–942. [Google Scholar]
- Hanewinckel, R.; van Oijen, M.; Ikram, M.A.; van Doorn, P.A. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016, 31, 5–20. [Google Scholar] [CrossRef]







| Touch disturbance | Pain disturbance | |
|---|---|---|
| Level 4 | type V, IV | type V, IV |
| Level 3 | type V, IV | type III, II, I |
| type III, II, I | type V, IV | |
| Level 2 | type III | type III |
| Level 1 | type III | type II, I |
| type II, I | type III | |
| Level 0 | type II, I | type II, I |
![]() |
| No | Questionnaire | Group E | Group E+N | Exposed (Total) |
Control |
|---|---|---|---|---|---|
| 1 | Sensory numbness in both hands | 43% | 55% | 50% | 2% |
| 2 | Sensory numbness in both legs | 38% | 47% | 44% | 1% |
| 3 | Hot sensation in the hand | 12% | 12% | 12% | 0% |
| 4 | Hot sensation in the leg | 17% | 20% | 19% | 0% |
| 5 | No pain when burn or wounded | 12% | 19% | 16% | 0% |
| 6 | Difficulty in judging the adequate temperature of bath water | 9% | 17% | 14% | 0% |
| 7 | Hanging a bag with elbow or shoulder instead of holding it in your hand | 32% | 36% | 34% | 2% |
| 8 | Headache | 36% | 28% | 32% | 0% |
| 9 | Shoulder stiffness | 65% | 68% | 67% | 9% |
| 10 | Lower back pain | 53% | 57% | 55% | 6% |
| 11 | Muscle cramps | 24% | 33% | 30% | 4% |
| 12 | Disturbed vision | 43% | 59% | 53% | 3% |
| 13 | Limited peripheral vision | 28% | 36% | 33% | 1% |
| 14 | Difficulty in recognizing a thing in your sight when you continue to stare it | 19% | 26% | 24% | 0% |
| 15 | Difficulty in finding a good in the shop | 39% | 33% | 35% | 1% |
| 16 | Difficulty in hearing | 27% | 47% | 39% | 10% |
| 17 | Difficulty in understanding a word or a sentence even if you can hear it | 8% | 16% | 13% | 1% |
| 18 | Tinnitus | 28% | 37% | 33% | 6% |
| 19 | Difficulty in smelling | 16% | 27% | 23% | 1% |
| 20 | Difficulty in tasting | 18% | 19% | 19% | 0% |
| 21 | Difficulty in judging the taste of your own cooking | 14% | 14% | 14% | 1% |
| 22 | Stumbling on flat ground | 4% | 12% | 9% | 0% |
| 23 | Difficulty in wearing slippers | 21% | 36% | 30% | 0% |
| 24 | Coming off your slippers or sandals while walking | 17% | 29% | 24% | 0% |
| 25 | Difficulty in fine finger task | 52% | 63% | 58% | 0% |
| 26 | Difficulty in buttoning | 14% | 38% | 29% | 0% |
| 27 | Dropping things in the hand | 14% | 26% | 21% | 0% |
| 28 | Dropping chopsticks while eating | 4% | 12% | 9% | 0% |
| 29 | Difficulty in speaking words or sentences well | 5% | 18% | 13% | 0% |
| 30 | Hand weakness | 57% | 59% | 58% | 2% |
| 31 | Leg weakness | 46% | 58% | 53% | 2% |
| 32 | Hand tremor while moving | 17% | 27% | 23% | 2% |
| 33 | Hand tremor at rest | 10% | 18% | 15% | 1% |
| 34 | Vertigo (feeling of spinning around) | 9% | 10% | 9% | 0% |
| 35 | Swaying dizziness | 8% | 8% | 8% | 0% |
| 36 | Fainting (syncope like) dizziness | 4% | 4% | 4% | 0% |
| 37 | Dizziness when standing up | 18% | 13% | 15% | 0% |
| 38 | General fatigue | 41% | 39% | 40% | 1% |
| 39 | Difficulty in sleeping | 31% | 41% | 37% | 4% |
| 40 | Appetite loss | 9% | 7% | 8% | 0% |
| 41 | No will to do anything | 23% | 27% | 26% | 1% |
| 42 | Cannot persevere or cannot keep working | 25% | 38% | 33% | 0% |
| 43 | Feeling as if your mind has become blank or empty | 3% | 10% | 7% | 0% |
| 44 | Cannot think about anything | 3% | 10% | 7% | 0% |
| 45 | Losing your train of thought during conversation | 10% | 16% | 14% | 0% |
| 46 | Forgetfulness | 32% | 41% | 37% | 1% |
| 47 | Feeling as if you are not yourself | 8% | 11% | 10% | 0% |
| 48 | Irritation | 32% | 31% | 31% | 0% |
| 49 | Feeling sad | 16% | 17% | 17% | 0% |
| 50 | Difficulty in finding something when interrupted | 22% | 30% | 27% | 2% |
| No | Questionnaire | Group E | Group E+N | Exposed (Total) |
Control |
|---|---|---|---|---|---|
| 1 | Sensory numbness in both hands | 90% | 91% | 91% | 8% |
| 2 | Sensory numbness in both legs | 90% | 83% | 86% | 8% |
| 3 | Hot sensation in the hand | 46% | 45% | 46% | 0% |
| 4 | Hot sensation in the leg | 56% | 55% | 56% | 1% |
| 5 | No pain when burn or wounded | 41% | 46% | 44% | 0% |
| 6 | Difficulty in judging the adequate temperature of bath water | 41% | 36% | 38% | 1% |
| 7 | Hanging a bag with elbow or shoulder instead of holding it in your hand | 68% | 71% | 70% | 3% |
| 8 | Headache | 86% | 82% | 83% | 23% |
| 9 | Shoulder stiffness | 96% | 92% | 94% | 50% |
| 10 | Lower back pain | 88% | 90% | 90% | 51% |
| 11 | Muscle cramps | 97% | 88% | 92% | 40% |
| 12 | Disturbed vision | 80% | 90% | 86% | 19% |
| 13 | Limited peripheral vision | 67% | 66% | 66% | 8% |
| 14 | Difficulty in recognizing a thing in your sight when you continue to stare it | 57% | 62% | 60% | 2% |
| 15 | Difficulty in finding a good in the shop | 78% | 71% | 74% | 9% |
| 16 | Difficulty in hearing | 62% | 79% | 72% | 20% |
| 17 | Difficulty in understanding a word or a sentence even if you can hear it | 49% | 52% | 51% | 7% |
| 18 | Tinnitus | 75% | 77% | 76% | 17% |
| 19 | Difficulty in smelling | 49% | 50% | 50% | 6% |
| 20 | Difficulty in tasting | 47% | 43% | 45% | 2% |
| 21 | Difficulty in judging the taste of your own cooking | 46% | 41% | 43% | 2% |
| 22 | Stumbling on flat ground | 64% | 72% | 68% | 2% |
| 23 | Difficulty in wearing slippers | 62% | 78% | 71% | 2% |
| 24 | Coming off your slippers or sandals while walking | 69% | 78% | 74% | 2% |
| 25 | Difficulty in fine finger task | 86% | 86% | 86% | 9% |
| 26 | Difficulty in buttoning | 53% | 69% | 62% | 0% |
| 27 | Dropping things in the hand | 76% | 80% | 78% | 7% |
| 28 | Dropping chopsticks while eating | 61% | 65% | 64% | 1% |
| 29 | Difficulty in speaking words or sentences well | 51% | 63% | 58% | 3% |
| 30 | Hand weakness | 83% | 84% | 84% | 7% |
| 31 | Leg weakness | 83% | 79% | 81% | 5% |
| 32 | Hand tremor while moving | 71% | 72% | 72% | 6% |
| 33 | Hand tremor at rest | 51% | 50% | 51% | 1% |
| 34 | Vertigo (feeling of spinning around) | 70% | 61% | 64% | 7% |
| 35 | Swaying dizziness | 57% | 58% | 58% | 5% |
| 36 | Fainting (syncope like) dizziness | 49% | 43% | 46% | 2% |
| 37 | Dizziness when standing up | 89% | 78% | 82% | 15% |
| 38 | General fatigue | 89% | 82% | 85% | 20% |
| 39 | Difficulty in sleeping | 86% | 78% | 81% | 21% |
| 40 | Appetite loss | 44% | 42% | 43% | 3% |
| 41 | No will to do anything | 85% | 88% | 86% | 21% |
| 42 | Cannot persevere or cannot keep working | 73% | 74% | 74% | 14% |
| 43 | Feeling as if your mind has become blank or empty | 56% | 56% | 56% | 6% |
| 44 | Cannot think about anything | 49% | 56% | 53% | 2% |
| 45 | Losing your train of thought during conversation | 68% | 73% | 71% | 8% |
| 46 | Forgetfulness | 96% | 95% | 95% | 59% |
| 47 | Feeling as if you are not yourself | 38% | 51% | 46% | 0% |
| 48 | Irritation | 94% | 81% | 86% | 33% |
| 49 | Feeling sad | 76% | 69% | 72% | 19% |
| 50 | Difficulty in finding something when interrupted | 81% | 80% | 81% | 15% |
| Findings | Group E | Group E+N | Exposed (Total) |
Control | |
|---|---|---|---|---|---|
| 1 | Dysarthria | 17.3% | 30.2% | 24.9% | 1.6% |
| 2 | Hearing loss | 28.9% | 53.7% | 43.5% | 7.8% |
| 3 | Visual field disturbance | 27.5% | 30.1% | 29.0% | 0.0% |
| 4 | Normal gait disturbance (distinct) | 25.9% | 25.4% | 25.6% | 0.0% |
| 5 | Normal gait disturbance (mild-distinct) | 30.9% | 41.2% | 36.9% | 0.0% |
| 6 | Tandem gait disturbance (distinct) | 17.3% | 34.5% | 27.4% | 1.6% |
| 7 | Tandem gait disturbance (mild-distinct) | 66.7% | 80.2% | 74.6% | 11.6% |
| 8 | Romberg sign | 5.3% | 10.3% | 8.2% | 0.8% |
| 9 | One-foot standing abnormality (eyes open) (distinct) | 21.5% | 41.4% | 33.3% | 1.5% |
| 10 | One-foot standing abnormality (eyes open) (mild-distinct) | 62.0% | 78.4% | 71.8% | 12.3% |
| 11 | Finger-nose test (eyes open) (distinct) | 14.8% | 26.7% | 21.8% | 0.0% |
| 12 | Finger-nose test (eyes open) (mild-distinct) | 46.9% | 59.5% | 54.3% | 0.0% |
| 13 | Adiadokokinesis (distinct) | 12.5% | 27.0% | 21.0% | 0.0% |
| 14 | Adiadokokinesis (mild-distinct) | 31.3% | 58.3% | 47.2% | 2.3% |
| 15 | Heel-knee test (distinct) | 18.3% | 27.3% | 23.5% | 0.0% |
| 16 | Heel-knee test (mild-distinct) | 49.3% | 55.6% | 52.9% | 2.3% |
| 17 | Postural hand tremor | 24.3% | 22.9% | 23.5% | 3.3% |
| 18 | Touch disturbance (four-limb peripheral) | 77.8% | 87.8% | 83.7% | 0.8% |
| 19 | Touch disturbance (oral) | 23.5% | 26.1% | 25.0% | 0.0% |
| 20 | Touch disturbance (systemic) | 21.0% | 16.5% | 18.4% | 0.0% |
| 21 | Pain disturbance (four-limb peripheral) | 93.8% | 95.7% | 94.9% | 1.5% |
| 22 | Pain disturbance (oral) | 35.8% | 49.1% | 43.7% | 0.0% |
| 23 | Pain disturbance (systemic) | 35.8% | 43.1% | 40.1% | 0.0% |
![]() |
| Age | n (M/F) | |
|---|---|---|
| General (V) | 65.9 ± 9.8 | 14 (6/8) |
| General + 4 Limbs (IV) | 66.8 ± 10.6 | 22 (12/10) |
| 4 Limbs (III) | 63.4 ± 10.0 | 128 (50/78) |
| 1-3 Limb(s) (II) | 57.6 ± 9.9 | 18 (6/12) |
| None(I) | 61.1 ± 15.5 | 15 (6/9) |
| Control | 63.7 ± 9.3 | 130 (51/79) |
| General (V) | General + 4 Limbs (IV) | 4 Limbs (II/I) | 1-3 Limb(s) (II) | None(I) | |
|---|---|---|---|---|---|
| General + 4 Limbs (IV) | 0.399 | ||||
| 4 Limbs (III) | 0.182 | 0.080 | |||
| 1-3 Limb(s) (II) | 0.012* | 0.004** | 0.011* | ||
| None(I) | 0.162 | 0.112 | 0.289 | 0.224 | |
| Control | 0.207 | 0.096 | 0.411 | 0.013* | 0.267 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).

